MT1 Flashcards
Volume of Distribution (Vd)
Vd = dose of drug / measured conc.
Half Life
t1/2 = (0.693*Vd) / CL (clearance)
Factors affecting Distribution
- organ blood flow
- molecular size ex. heparin
- lipid solubility (*brain)
- plasma protein binding (10-99%)
Metabolism
Liver via 2 processes:
Phase 1: Biotransformation
*oxidative / reductive / hydrolytic rxns –> P450 (CYP) monooxygenase system
Phase 2: conjugation rxns –> liver enzymes
Metabolism Phase II
commonly added molecules
- glucuronic acid
- sulfate
- carboxylic acid
Excretion (kidney - renal)
- passive glomerular filtration
- active tubular secretion
- passive tubular reabsorption (urine pH is key)
Excretion (bile)
Liver –> intestine via common bile duct
- larger drugs
- conjugated metabolites
(carrier mediated process)
Viral Replication
APURAR
Covid-19 virus
- ssRNA
- 125nm diamter
- genomic proofreading mech.
RDRP inhibitors
- remdesivir
- ribavirin
- favipiravir
MOA: RDV-TP resembles ATP and competes w the nucleotide during viral RNA synth. RDV-TP forms phosphodiester bond w next nucleotide
MIC vs MBC
MIC: lowest conc. of antibiotic that inhibits visible growth of a microorganism after overnight incubation
MBC: min bacteriocidal conc.
MBC:MIC
- less than or equal to 4 is bacteriocidal
- over 4 is bacteriostatic
b- lactam antibiotics
Penicillin
MOA: inhibits synth of bacterial PG cell wall
Macrolides (antibiotic)
Azithromycin (product of actinomycetes)
MOA: inhibits bacterial protein synth by binding reversibly to 50S ribosomal subunit
Aminoglycosides (antimicrobial)
Gentamicin
MOA:
- interferes w bacterial protein synth by irreversibly binding 30 and 50S subunits
- creates fissures in outer membranes of bacteria
Tetracyclines (antimicrobial)
Doxycycline
MOA:
- inhibits bacterial protein synth by binding REVERSIBLY to 30S subunit (and possibly 50S)
- cause changes in cytoplasmic membrane
Sulfonamides (antimicrobial)
Sulfamethoxazole
MOA: interferes w folic acid synth by inhibiting dihydropteroate synthetase and prevents addition of para-aminobenzoic acid (PABA) into folic acid
Quinolones (antimicrobial)
Ciprofloxacin
MOA: inhibits DNA gyrase/ topoisomerase
Glycopeptides (antimicrobial)
Vancomycin
MOA: inhibits cell wall synth in gram + bacteria by binding to the D-alanyl-D-alanine terminus of cell wall precursor units
Oxazolidinone (antimicrobial)
Linezolid
MOA: inhibits protein synth by binding at the P site of the 50S ribosomal subunit
TNM classification of solid tumours
T: extent of primary tumour (size)
N: presence/absence and extent of regional lymph node metastasis
M: presence/absence of distant metastasis
Chemotherapy
MOA: damage DNA/ interfere with DNA synthesis
- phase specific vs nonspecific agents
- most cytotoxic to cells w high growth fraction
Akylating agents (chemotherapy)
Cyclophosphamide
MOA: bind DNA by creating covalent bonds that cross-link DNA –> prevents unwinding of DNA –> decreased protein synth.
Epipodophyllotoxins (chemotherapy)
Etoposide
MOA: inhibits topoisomerase II, inhibits DNA synth.
Taxanes (chemotherapy)
Docetaxel
MOA:
- promotes assembly and stabilization of microtubules (prevents cell replication)
- may also inhibit angiogenesis (blood vessel formation)
Antimetabolites (chemotherapy)
5-Fluorouracil (5-FU)
MOA:
- resemble naturally occurring nuclear structural components
- incorporate into DNA or RNA
- may also inhibit enzymes involved in synthesis of DNA or proteins (ex. polymerase)
Antitumour antibiotics (chemotherapy)
Doxorubicin
MOA:
- insert bw DNA base pairs, uncoil DNA, inhibit synth
- may also inhibit polymerase
Alkylating agent + antitumour antibiotic
Streptozocin
- naturally occurring methylnitrosurea
- specific for b and exorine cells of pancreas due to an attached sugar moiety
MOA: undergoes spontaneous decomp. –> reactive methylcarbonium ions –> alkylate DNA –> interstrand cross links –> inhibits mitosis
Camptothecins (chemotherapy)
Irinotecan
MOA: bind topoisomerase I, prevents religation of DNA strand
- results in cell death
Vinka Alkaloids (chemotherapy)
Vincristine
MOA: prevent polymerization of tubulin to form microtubules
- induce depolymerization of formed tubules
- inhibits mitosis
Targeted Therapy
Monoclonal antibodies
ex. Trastuzumab (Herceptin): Anti-HER2 (breast cancer cells)
Endocrine therapy
Aromatase inhibitors
ex. Letrozole
Catecholamines
- dopamine
- NE
- epinephrine
(all synth. from tyrosine)